Eliksa Therapeutics
3 known investors
Find your way into Eliksa Therapeutics
Sign up to find every way you can get introduced to Eliksa Therapeutics
- Your email: who you already know at Eliksa Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eliksa Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Eliksa Therapeutics develops innovative treatments for rare diseases with unmet medical needs.
Investors · 3
Militia Hill Ventures✓ confirmed by Eliksa TherapeuticsPhiladelphia
How we know: the company's own site · Not right? Tell us
Ben Franklin Technology Partners✓ confirmed by Eliksa TherapeuticsHarrisburg · $50K – $250K
How we know: the company's own site · Not right? Tell us
BioAdvancelisted by BioAdvanceConshohocken · $500K – $1.5M
How we know: BioAdvance's portfolio page · press coverage · funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Eliksa Therapeutics do?
- Eliksa Therapeutics develops innovative treatments for rare diseases with unmet medical needs.
- Who are Eliksa Therapeutics's investors?
- Eliksa Therapeutics's investors include Militia Hill Ventures, Ben Franklin Technology Partners, BioAdvance.



